liver cancer

Roche’s Tecentriq and Avastin Combination Offers New Hope for Early-Stage Liver Cancer Patients

Ad hoc announcement pursuant to Art. 53 LR (PRESS RELEASE) BASEL, 19-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY),…

1 year ago

L’association Tecentriq et Avastin de Roche offre un nouvel espoir aux patients atteints d’un cancer du foie à un stade précoce

Annonce ad hoc conformément à l'art. 53LR (COMMUNIQUÉ DE PRESSE) BÂLE, 19-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY),…

1 year ago

Metadeq Announces Breakthrough Non-Invasive Blood Test that Solves NASH Diagnosis Problem

New test featured today in Gut, a leading international journal published by BMJ, uses A.I. to accurately predict the stages…

2 years ago

950 treatment naïve genotype-1b patients enrolled for two of Boehringer Ingelheim pivotal Phase III interferon-free hepatitis C clinical trials

Over 950 patients have now been successfully enrolled in the pivotal Phase III HCVerso™1 and 2 trials The Phase III…

11 years ago